Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.
Sign the petition to put Belzutifan on the PBS NeuroEndocrine Cancer Australia is calling on our community to help improve the lives of VHL patients
Recognising the critical importance of collaboration and advocacy behind the scenes, the NECA Team embraces the opportunity to contribute to shaping the landscape for Neuroendocrine
It is with deep gratitude to Ryan Harding’s advocacy work that we thank him for taking time out of his very busy schedule to advocate
NET Patient and passionate advocate and fundraiser Rob Hammond shared his story and the plight of NET Patients Australia wide at the Senate Inquiry into
NeuroEndocrine Cancer Australia is calling on our community to help improve the lives of Von Hippel-Lindau (VHL) patients in Australia.
VHL is a rare genetic form of neuroendocrine cancer.
We need the help of the Australian community to put Belzutifan onto the PBS list.